top of page
Browse by category
Search


First dual GCG/GLP-1ra gains approval from China’s NMPA for chronic weight management
China's National Medical Products Administration (NMPA) has approved Innovent Biologics’ mazdutide, a first-in-class dual glucagon...


Levita Magnetics' Magnetic Surgical System gains indication for bariatric and hiatal hernia repair procedures
Levita Magnetics has gained FDA clearance for the use of its Magnetic Surgical System (MSS), combined with the MARS system, in bariatric...


Johnson & Johnson MedTech launches the ETHICON 4000 Stapler
Johnson & Johnson MedTech has launched the ETHICON 4000 Stapler, an advanced surgical stapler designed to manage tissue complexities and...


Johnson & Johnson MedTech launches the DUALTO Energy System combining multiple energy modalities into an integrated platform for use across open and minimally invasive surgery
Johnson & Johnson MedTech has launched the DUALTO Energy System, a surgical solution that combines multiple energy modalities into an...


Novo Nordisk and Septerna to develop oral small molecule medicines for obesity
Novo Nordisk and Septerna have announced an exclusive global collaboration and license agreement to discover, develop and commercialise...


Fractyl Health submits of CTA module in Europe for RJVA-001
Fractyl Health has submitted the first module of its Clinical Trial Application (CTA) in Europe for the company’s gene therapy candidate...


Bariatric Solutions International's 20th Anniversary Supplement
To read or download this supplement in full, please click on the file below


FDA accepts filing application for oral semaglutide 25mg
Novo Nordisk has announced that the FDA accepted its New Drug Application (NDA) submission for an investigational once-daily, 25mg oral...


First RYGB cases performed with Johnson & Johnson MedTech’s OTTAVA Robotic Surgical System
Johnson & Johnson MedTech has completed the first cases in the clinical trial for the OTTAVA Robotic Surgical System, the first clinical...


Soleno Therapeutics launches VYKAT XR for patients with Prader-Willi syndrome
Soleno Therapeutics has launched VYKAT XR (diazoxide choline) extended-release tablets, the company’s treatment for hyperphagia in...
Browse by tag






bottom of page

